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Abstract Lethal toxin (LeTx) plays a central role in anthrax
pathogenesis, however a cytotoxicity of LeTx has been di⁄cult
to demonstrate in vitro. No cytolytic e¡ect has been reported for
human cells, in contrast to murine cell lines, indicating that cell
lysis can not be considered as a marker of LeTx activity. We
have recently shown that murine macrophage-like RAW 264.7
cells treated with LeTx or infected with anthrax spores under-
went changes typical of apoptotic death. Here we demonstrate
that cells from human peripheral blood display a proapoptotic
behavior similar to murine cells. TUNEL assay detected a nu-
cleosomal degradation typical of apoptosis in peripheral blood
mononuclear cells (PBMC) treated with LeTx. Membrane
staining with apoptotic dyes was detected in macrophages de-
rived from monocytes in presence of LeTx. The toxin inhibited
production of proin£ammatory cytokines in PBMC stimulated
with a preparation of Bacillus anthracis cell wall. Infection of
PBMC with anthrax spores led to the appearance of a large
population of cells stained positively for apoptosis, with a re-
duced capacity to eliminate spores and vegetative bacteria. The
aminopeptidase inhibitor, bestatin, capable of protecting cells
from LeTx, restored a bactericidal activity of infected cells.
These ¢ndings may be explained by LeTx expression within
phagocytes and support an important role of LeTx as an early
intracellular virulence factor contributing to bacterial dissemi-
nation and disease progression. 3 2002 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Macrophages have long been implicated in the development
of inhalational anthrax. In the process of antimicrobial re-
sponse the alveolar macrophages engulf the inhaled spores
and carry them to mediastinal lymph nodes. A cascade of
intracellular reactions becomes induced to eliminate pathogen.
However, lethal doses of spores can overwhelm a bactericidal
capacity of macrophages. As a result, some spores survive and
germinate within the macrophages producing an antiphago-
cytic capsule and two toxins (lethal toxin, LeTx; and edema
toxin, EdTx). Escape of bacilli from infected cells allows re-
lease and proliferation of the bacteria in the lymphatic system
and consequent development of systemic disease [1]. LeTx
plays a central role in anthrax pathogenesis, and macrophages
were suggested as major mediators of its activity because it
has been shown that mice depleted of macrophages are resis-
tant to lethal doses of toxin [2^4]. However, the toxicity of
LeTx in vitro was di⁄cult to demonstrate. Cytolysis after
LeTx treatment was reported only in a few cases, such as
peritoneal exudate macrophages from C3H/HeNHsd mice
[5], as well as murine macrophage cell lines, RAW 264.7
and J774.A1 [2,6]. No cytopathic e¡ect was reported for hu-
man blood cells [5,7] indicating that cell lysis was not a bio-
logically relevant e¡ect of LeTx or perhaps that human cells
of monocyte/macrophage origin were not susceptible to LeTx.
We have recently shown that RAW 264.7 cells undergo
changes typical of apoptotic death at concentrations lower
than required for lysis [8]. In agreement with this we detected
cellular membrane apoptotic changes in the cells infected with
anthrax spores. Here we demonstrate that the infected human
peripheral blood mononuclear cells (PBMC) behave similar to
the murine cells. In both systems a bactericidal capacity of
cells decreases as a result of either LeTx treatment or intra-
cellular infectious process. A correlation between LeTx-in-
duced apoptosis and the impairment in monocyte/macrophage
function is further supported by ¢nding that a LeTx inhibitor,
bestatin, displays a protection of the infected cells.
2. Materials and methods
2.1. Reagents
Chromatographically puri¢ed recombinant Bacillus anthracis lethal
factor (LF) and protective antigen (PA) were kindly provided by Dr.
S. Leppla (National Institutes of Health, USA) [9,10]. B. anthracis
(Sterne) spores were prepared similar as described in [11]. Cells
from the overnight starter culture grown in NB medium (Gibco,
USA) without antibiotic at 37‡C were plated onto NB agar and fur-
ther incubated at 37‡C. When the ratio of spores to vegetative bac-
teria detected by phase-contrast microscopy reached 99:1, the spores
were removed from the agar surface with water, pelleted at 5000Ug
for 30 min, washed ¢ve times with distilled water, then the concen-
tration was adjusted to 1U109 spores/ml. Flow cytometry experiments
were carried out in a FACSCalibur1 Becton Dickinson Immunocy-
tometry System (BD Biosciences, USA). Statistical analysis was per-
formed by Student’s t-test. Error bars correspond to 95% con¢dence.
2.2. Cells and cell culture
PBMC and monocytes were isolated from whole blood obtained
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from 41 American Red Cross volunteers (Rockville, MD, USA) using
Fico/Lite LymphoH (Atlanta Biologicals, USA) according to estab-
lished procedures [12]. Monocytes were further isolated from PBMC
by cell attachment onto a tissue culture dish overnight. The non-ad-
herent cells were washed away, and the adherent fraction containing
isolated monocytes was removed using a Cellstripper solution (Media-
tech, USA). Alternatively, monocytes were negatively selected using
a magnetically activated cell sorting (MACS) cell isolator (Milteny
Biotec Inc., Germany). PBMC and monocytes were cultured in
DMEM/F12 supplemented with 10% fetal bovine serum, 2 mM
L-glutamine, 100 U/ml penicillin, 100 Wg/ml streptomycin (Sigma-
Aldrich, USA) at 37‡C in 5% CO2. Phenol red and antibiotics were
omitted when indicated.
2.3. Cell treatment with LeTx
Human cells were treated with 0.05^0.5 Wg/ml of LF. PA concen-
tration was kept constant at 0.1 or 0.5 Wg/ml. When indicated, cells
were preactivated with recombinant INF-Q (100 U/ml; RpD Systems,
USA) for at least 24^48 h.
After incubation at 37‡C (5% CO2) for 48 h, the supernatants were
collected and stored at 380‡C.
2.4. Apoptosis assay
For staining with YO-PRO0-1/propidium iodide (Vibrant Apopto-
sis Assay Kit #4, Molecular Probes, USA), cells were stripped from
plastic and suspended in 900 Wl of phosphate-bu¡ered saline (PBS)
with 100 Wl of stain (prepared according to manufacturer’s instruc-
tions). Staining was carried out at 4‡C for 30 min. At least 4000 cells
were counted for each sample over a constant period of time. Stau-
rosporine (Alexis Biochemicals, USA) was used as an inducer of ap-
optosis at 50 WM.
TUNEL assay was carried out with in situ cell death detection kit
(Roche Molecular Biochemicals, USA). Cells were stripped from plas-
tic and suspended in 100 Wl of PBS.
2.5. Preparation of cell wall
The B. anthracis cell wall has been obtained essentially as described
by Lemaire et al. [13] with modi¢cations introduced by Chauvaux et
al. for B. anthracis [14]. The cell wall components isolated by this
method are mainly peptidoglycan and teichoic acid [13]. B. anthracis
(Sterne strain) was grown in LB medium (Gibco, USA). Bacterial
cultures were incubated until they reached late exponential phase
and were then harvested by centrifugation (5000Ug, 37‡C, 10 min),
washed in distilled endotoxin-free water, and boiled in 8% sodium
dodecyl sulfate (SDS) (Sigma-Aldrich) for 30 min. Cells were incuba-
ted at room temperature overnight and centrifuged at 25,000 g for
20 min. Supernatant was discarded and the cell pellet was resuspended
in 4% SDS, boiled for 15 min, and centrifuged at 25,000 g for 20 min.
The remaining cell pellet was resuspended in distilled water and cen-
trifuged at 25 000Ug for 20 min. This procedure was repeated three
times. Finally, the pellet was resuspended in 2 M NaCl and centri-
fuged at 25 000Ug for 20 min; the pellet was then resuspended in
distilled water and centrifuged at 25 000Ug for 20 min. Supernatant
was discarded and the remaining pellet dried. The concentration of
cell walls was determined by measuring turbidity of the suspension at
600 nm. Cell walls were checked for absence of aerobic and anaerobic
bacterial contamination using various bacterial growth media, and for
endotoxin (Escherichia coli) using the Limulus amebocyte lysate test
(Sigma-Aldrich). The peptide content determined by Bio-Rad protein
assay (USA) is 0.9% (w/w), teichoic acid content is 4.0% (w/w).
2.6. Cytokine release assay
PBMC (1U106/ml) were plated in 24-well tissue plates (Nalge
Nunc, USA) and varying amounts of cell wall and LeTx were added
for 48 h. Cell culture supernatants were harvested and analyzed for
released cytokines (TNF-K, IL-6, IL-1L, and IFN-Q ; IL-10; BD Phar-
mingen) by enzyme-linked immunosorbent assay (ELISA) according
manufacturer’s recommendations.
2.7. Alamar blue assay
Alamar blue is a water-soluble, non-toxic, £uorometric/colorimetric
growth indicator that measures cell metabolism. Cellular growth and
metabolism reduce Alamar blue dye and cause a color change from
blue to red. Alamar blue has been extensively used in experiments on
antibacterial e¡ects of di¡erent substances [15]. B. anthracis cells grow
as chains of di¡erent length. It makes the assay based on plaque
forming unit counts unreliable. In this case, the Alamar blue assay
is especially suitable for quantitative measurement of bacterial viabil-
ity. The Alamar blue assay has been used by us in a microplate format
[16]. Each plate included control wells with known amount of
B. anthracis spores for determination of the dose^response curve.
3. Results
3.1. LeTx causes apoptotic changes in activated monocytes
(AM)
High level of systemic bacteremia is a typical feature of
anthrax. To study pathogenicity of B. anthracis on human
blood cells, we tested the e¡ect of LeTx on freshly isolated
PBMC and monocytes. The cells were resistant to lysis in
presence of LeTx, in contrast to mouse RAW 264.7 cells. At
the highest concentration of LeTx tested (0.5 Wg/ml LF and
0.5 Wg/ml PA), no lysis or changes in £uorescence staining
patterns (see below) were detected after 15^24 h incubation
Fig. 1. Staining of LeTx-treated human peripheral blood monocytes preincubated with IFN-Q (100 U/ml) for 48 h. Cells were treated with dif-
ferent concentrations of toxin for 15 h in culture media with (A) or without (B) 10% FCS. Cells were analyzed by £ow cytometry after staining
with YO-PRO-1 (apoptosis-speci¢c, green £uorescent) and propidium iodide (PI; late apoptosis and necrosis-speci¢c, red £uorescent) using a
gate region corresponding to necrotic and apoptotic cells. Thick line, PA (0.5 Wg/ml)+LF (0.5 Wg/ml); dotted line, control with staurosporine
(50 WM). Gray area, PA (0.5 Wg/ml) and untreated cells.
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using cells isolated from di¡erent donors (data not shown).
This is consistent with the results of earlier studies unable to
demonstrate cytolysis in cells of human origin upon treatment
with anthrax culture ¢ltrates or puri¢ed anthrax toxins [5,7].
Human blood monocytes, however, are capable to respond to
LeTx treatment by the induction of bystander lymphocyte
proliferation [17]. We therefore isolated peripheral blood
monocytes and studied the behavior in presence of LeTx.
Human monocytes undergo rapid spontaneous apoptosis
upon culture in vitro unless provided with speci¢c survival
signals such as IFN-Q, or microbial products such as lipopoly-
saccharide (LPS) [18,19]. In our experiments monocytes were
activated with IFN-Q for 48 h and then treated with LeTx for
15^24 h. The activated monocytes (AM) were used for £ow
cytometry experiments after staining with YO-PRO-1, a green
£uorescent dye capable of detecting early apoptosis-speci¢c
changes in membrane permeability and composition, and pro-
pidium iodide (PI), a late apoptosis/necrosis-speci¢c red £uo-
rescent dye. Signals from the cells that acquired additional
green and/or red £uorescences during the course of treatment
were gated and plotted as histograms in Fig. 1. A spontaneous
cell death in control experiments with untreated cells resulted
in the appearance of the high intensity peak in Fig. 1A (about
50% of total cells). Treatment with PA only did not lead to
the additional change of the histogram. Cells treated with
LeTx, compared to untreated cells, showed a higher intensity
of £uorescence in the region typical of early apoptotic cells
(¢rst peak in Fig. 1A) similar to that of staurosporine as a
positive control for apoptosis [20]. Removal of serum from
the culture media substantially increased the rate of sponta-
neous apoptosis (Fig. 1B) in agreement with previous data
[21]. In these stress conditions the AM became considerably
more susceptible to LeTx (Fig. 1B). The number of green
£uorescent cells in the early apoptotic region relative to un-
treated control increased, while the number of double-stained
cells decreased, showing a change in a cellular death status.
We also detected LeTx-induced nucleosomal fragmentation
typical for apoptosis [22] using TUNEL assay (Fig. 2). The
in situ modi¢cation of the assay we used employs terminal
deoxynucleotidyl transferase to incorporate £uorescent nucle-
otide derivatives into the DNA strand breaks generated in the
apoptotic process. The results in Fig. 2 show that both treat-
ments with LeTx and PA alone induced DNA fragmentation
detected by £ow cytometry as an increase in cell £uorescence.
3.2. LeTx suppresses the innate immune response and inhibits
bactericidal activity of PBMC
Bacterial infection typically induces a proin£ammatory re-
sponse of PBMC and other immune cells as a result of the
innate signaling through receptors capable of recognizing a
variety of antigens of both Gram-negative and Gram-positive
bacteria [23]. We suggested that one of the possible pathogen-
ic functions of LeTx could consist in the suppression of the
innate response of monocytes/macrophages and, perhaps, oth-
er cell types present in PBMC. Induction of proin£ammatory
cytokines in LeTx-treated PBMC by surface antigens of an-
thrax bacillus, such as cell wall components (CW), could be
used as a sensitive indicator of this process. Indeed, PBMC
stimulated with anthrax CW responded by strong increase in
the production of IL-1L, TNF-K and IL-6, typical for the
innate immune response (Fig. 3), whereas LeTx treatment
Fig. 2. TUNEL assay of nucleosomal degradation of PBMC in the
presence of LeTx. Cells were preincubated with IFN-Q (100 U/ml)
for 48 h and treated with toxin for 15 h in culture media. Staining
was measured by £ow cytometry. Dotted line, PA (0.5 Wg/ml); thick
solid line, PA (0.5 Wg/ml)+LF (0.5 Wg/ml); thin solid line, staurospo-
rine (50 WM) as positive control. Gray area, LeTx-untreated control
cells incubated in the conditions of the assay. Fluorescence in a
green channel was recorded.
Fig. 3. Production of proin£ammatory cytokines by human PBMC
activated by CW in presence of LeTx. Cytokine release was detected
by ELISA after 48 h stimulation: cells only control (lane 1); CW,
1 Wg/ml (lane 2); CW, 0.5 Wg/ml (lane 3); CW, 0.1 Wg/ml (lane 4);
LF, 0.5 Wg/ml+PA, 0.1 Wg/ml (lane 5); CW, 1 Wg/ml+LF, 0.5 Wg/
ml+PA, 0.1 Wg/ml (lane 6); CW, 0.5 Wg/ml+LF, 0.5 Wg/ml+PA,
0.1 Wg/ml (lane 7); CW, 0.1 Wg/ml+LF, 0.5 Wg/ml+PA, 0.1 Wg/ml
(lane 8); LF, 0.5 Wg/ml (lane 9); PA, 0.1 Wg/ml (lane 10); LPS,
0.01 Wg/ml (lane 11).
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e¡ectively abrogated the induction of the cytokine release.
Similar e¡ect was found in experiments with isolated AM
(data no shown).
3.3. Anthrax infection in AM results in apoptosis-positive cells
The apoptotic morphology of human AM treated with
LeTx, combined with the observation that the LF, EF, and
PA genes are expressed early in the infection process [1], has
prompted us to study the possibility of detecting apoptosis in
spore-infected blood cells (Fig. 4). Flow cytometry o¡ers a
convenient way of monitoring the infectious process in cells
stained with apoptotic dyes at di¡erent time points after the
addition of spores. Gating of scatter plots allows almost com-
plete separation of signals from spores/vegetative bacilli and
infected cells on £uorescence plots. It has been found that the
development of infection resulted in the gradual increase of
the cell green £uorescence as well as the appearance of the
additional peak with high both green and red £uorescences.
Within 24 h of infection the cell population corresponding to
uninfected cells disappeared, while the intensity of cell stained
positively for apoptosis-like membrane permeability changes
considerably increased.
We also studied survival of anthrax spores in the infected
human PBMC. In order to evaluate the role of the expressed
LeTx in the intracellular infection, the infected cells were
treated with di¡erent amounts of bestatin, a known inhibitor
of LeTx [24]. In the presence of bestatin, the antimicrobial
activity of PBMC increased in a concentration-dependent
manner (Fig. 5). Under the conditions of the experiment the
intrinsic antibiotic activity of bestatin was undetectable (data
not shown).
4. Discussion
LeTx is considered to be a major anthrax virulence factor.
Paradoxically, experiments with animals demonstrated that
the strains of mice sensitive to toxin were relatively resistant
to anthrax infection [25,26]. Both humans and rodents are
susceptible species, however, no correlates were found be-
tween LeTx activity detectable in vitro and the infectious pro-
cess. There are only a limited number of available in vitro
systems where biological activity of LeTx has been demon-
strated. The murine macrophage-like cell lines, RAW 264.7
and J774.A1 are among the most susceptible to the cytolysis
by LeTx, while a majority of other cells, including human
white blood cells, are resistant [5,7]. The intracellular enzy-
matic activity of LeTx toward mitogen-activated protein ki-
nase kinases (MAPKKs) [27^30] does not correlate with the
resistance.
This study aimed to investigate the cytopathological e¡ect
of LeTx in human PBMC and its relevance to human disease.
Fig. 4. Anthrax infection results in apoptosis of PBMC. Histogram
of green £uorescence of PBMC in £ow cytometry experiment 24 h
after infection with anthrax (Sterne) spores. Gray area, uninfected
cells. Staining was as in Fig. 1. The spore:cell ratio was 10:1. Sig-
nals from growing bacterial cells were excluded by gating using a
scatter plot.
Fig. 5. Bestatin increases bactericidal activity of human PBMC infected with anthrax (Sterne) spores. Cells (2U105/well) were incubated with
bestatin for 1 h, then spores were added to cells for 3 h. After incubation the cells were lysed, and the viability of remaining spores and vegeta-
tive bacteria was determined using the Alamar blue technique. The spore:cell ratio was 10:1. PBMC from two donors were used. Before addi-
tion of spores the PBMC were prestimulated with IFN-Q (100 U/ml) for 24 h.
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Our ¢ndings show that anthrax infection in both mouse [8]
and human phagocytes leads to the reduction in their bacte-
ricidal capacity against spores and germinating bacilli, and the
appearance of apoptotic cells. Apoptosis changes in cell mem-
brane and nucleosomal fragmentation can also be found in
LeTx-treated human PBMC and monocytes. PA alone was
also able to cause DNA fragmentation, perhaps as a result
of its membrane permeabilizing activity. Similar e¡ect was
previously described for staphylococcal K-toxin capable of
forming transmembrane pores [31].
Apoptosis and proliferation may be viewed in terms of a
‘growth equation’, where the fate of the cell depends on the
relative intensity of growth and death stimuli [32]. LeTx is
known to inactivate a MAPKK [27^30] but this inactivation
per se does not provide a direct apoptotic stimulus. It is in-
teresting to speculate that proliferation of susceptible cell lines
like RAW 264.7 depends on the continuous signaling through
MAPK pathways [33], while in human monocytes, rapidly
undergoing spontaneous apoptosis in culture, a contribution
of the MAPK survival stimulus is low. As a result, RAW
264.7 cells rapidly become apoptotic in presence of LeTx. In
contrast, the e¡ect of LeTx on human monocyte apoptosis
can be detected only after an additional stress signal. We
have demonstrated that conditions of serum withdrawal in
presence of IFN-Q substantially increase the susceptibility of
monocytes to LeTx (Fig. 1). Serum starvation is known to
increase Fas-mediated apoptosis in human diploid ¢broblasts
[34], and to activate stress-responsive JNK pathway in neuro-
nal cells [35]. We previously presented evidence that Fas ^
FasL interaction could be involved in the mechanism of
LeTx activity in mouse RAW 264.7 cells [8]. Consistent with
this, Fas activates the p38 and JNK pathways in Jurkat cells
[36], the latter of which is known to be required for induction
of FasL promoter activity in response to various stress stimuli
[37].
The apoptotic changes in AM explain the ability of LeTx to
reduce production of proin£ammatory cytokines by cells
stimulated through innate immune receptors [23]. Macro-
phage inactivation but not direct killing may contribute to
bacterial dissemination and disease progression. The fact
that bestatin, the inhibitor of cell signaling pathways induced
by LeTx [17], reduces bacterial burden in infected AM impli-
cates LeTx as an early intracellular virulence factor secreted
by vegetating bacilli within macrophages. This conclusion is
supported by the data on the reduced survival of the isogenic
Sterne strain mutant with deletion of LeTx and PA genes,
compared to the Sterne strain, in murine RAW 264.7 macro-
phages [11]. Our results suggest that a proin£ammatory status
of macrophages rather than cytolysis can be considered as a
marker of cell susceptibility to LeTx.
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